
    
      In patients with advanced NSCLC to compare the added benefit of High Dose Rate Intraluminal
      Brachytherapy (HDRIB) with External Beam Radiation (EBR). Benefit will be assessed by
      measuring the proportion of patients who achieve symptomatic improvement in lung cancer
      symptoms.
    
  